Given the small sample size in both studies, this difference may not be significant; furthermore, a portion of the patients in this gepant cohort had insufficient response to prior injectable monoclonal antibody.
← all excerpts
Gepants for headache prevention in children and adolescents: A multicenter chart review study.
1
—
—